Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vision Medicines
Vision Medicines

Vision Medicines

Series A

Vision Medicines develops promising drugs for rare genetic diseases, backed by a world-class scientific board.

HQ
Cambridge, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees

Vision Medicines focuses on developing innovative drugs for rare genetic diseases, including Stargardt disease and other conditions caused by inborn errors of aldehyde metabolism. The company is dedicated to advancing treatments that address unmet medical needs, leveraging cutting-edge research and a world-class scientific advisory board.

Vision Medicines has made significant strides in the field of retinal biology and genetics, assembling a team of leading scientists and clinicians. Their promising drug candidates have the potential to transform the treatment landscape for rare diseases, demonstrating substantial impact in the biotech industry.

Vision Medicines - Similar Companies

Viscient Bio logo

Viscient Bio

Cygnal Therapeutics logo

Cygnal Therapeutics

Rheos Medicines logo

Rheos Medicines

Fog Pharmaceuticals logo

Fog Pharmaceuticals

fogpharma.com

GentiBio logo

GentiBio

gentibio.com

Quiver Bioscience logo

Quiver Bioscience

MingSight Pharmaceuticals logo

MingSight Pharmaceuticals

mingsight.com

Blade Therapeutics logo

Blade Therapeutics

Visus Therapeutics logo

Visus Therapeutics

visustx.com

Visiox logo

Visiox

visioxpharma.com

Generate Biomedicines logo

Generate Biomedicines

ReVision Therapeutics logo

ReVision Therapeutics

Joinn Biologics logo

Joinn Biologics

joinnbio.com

BioHybrid Solutions logo

BioHybrid Solutions

Iview Therapeutics logo

Iview Therapeutics

Vision Medicines - Quick Facts

Who are Vision Medicines' competitors?

Companies similar to Vision Medicines include Viscient Bio, Cygnal Therapeutics, Rheos Medicines and Fog Pharmaceuticals.

When was Vision Medicines founded?

Vision Medicines was founded in 2013.

Where is Vision Medicines' headquarters located?

Vision Medicines' headquarters is located in Cambridge, MA, US.

When was Vision Medicines' last funding round?

Vision Medicines' most recent funding round was for $7.5M (USD) in November 2015.

How much has Vision Medicines raised to-date?

As of Nov 9, 2015, Vision Medicines has raised a total of $7.5M (USD).

How many employees does Vision Medicines have?

Vision Medicines has 30 employees as of Feb 4, 2024.

Vision Medicines - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research